Takeda Pharmaceutical Co Ltd
NYSE:TAK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
AST SpaceMobile Inc
NASDAQ:ASTS
|
US |
|
A
|
Aptargroup Inc
F:AGT
|
US |
|
E ON SE
MIL:EOAN
|
DE |
|
S
|
Securitas AB
XMUN:S7MB
|
SE |
|
M
|
Mercer International Inc
F:AEZ
|
CA |
|
ONE Gas Inc
NYSE:OGS
|
US |
|
Schneider National Inc
F:SNIA
|
US |
Wall St Price Targets
TAK Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TAK is 19.501 USD with a low forecast of 16.215 USD and a high forecast of 25.609 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TAK's stock price target?
Price Target
19.501
USD
According to Wall Street analysts, the average 1-year price target for TAK is 19.501 USD with a low forecast of 16.215 USD and a high forecast of 25.609 USD.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is -24%.
